INVO Fertility reports Q3 EPS (77c) vs ($15.11) last year

Reports Q3 revenue $1.76M vs $1.4M last year. “This quarter showcased meaningful progress across the two core pillars of our growth strategy: strengthening organic performance within our existing operations and advancing accretive acquisition opportunities,” commented Steve Shum, CEO of INVO Fertility (IVF). “We saw a robust 18% organic growth across our clinics driven by higher patient volume and increased awareness of our fertility services. This resulted from our enhanced marketing efforts, expanded telehealth reach, and continued investment in a comprehensive suite of fertility offerings, helping more individuals and families access the care they need. At the same time, policy momentum continues to build, with recent federal updates enabling employers to offer standalone infertility benefits-an important step forward in further expanding access to IVF and related treatments nationwide and driving continued strong growth for our industry.”